e-Edition
Obituaries
Special Sections
Special Occasions
Contact

Subscribe
Paywall Login
Login to Comment
Register

December 11th, 2017

jobs

homes

Home
News
Sports
Business
Entertainment
Classifieds
Commentary

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY:GSK)

52.09 -0.87 (-1.63%)

Streaming Delayed Price Updated: 11:23 AM EDT, Aug 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about GSK plc American Depositary Shares (Each representing two Ordinary Shares)

< Previous 1 2

...

28 29 30 31 32 33 34 35 36

...

45 46 Next >

Drug Behemoth GSK Delivers Strong Beat And Raise, But Shares Fell ↗

July 27, 2022

The company expects full-year sales to grow 6%-8% and for earnings to rise 1%.

Via Investor's Business Daily

Jim Cramer Says This Stock Costs About $3, But 'If You Wait Long Enough' You Can Buy It For $2 ↗

July 27, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes Blackstone Inc. (NYSE: BX) over Apollo Global Management Inc (NYSE: APO).

Via Benzinga

Benzinga Before The Bell: Twitter Shareholder Proposal Date Set, T-Mobile's Strong FY22 Outlook, Shopify's Job Cuts And Other Top Financial Stories Wednesday, July 27 ↗

July 27, 2022

Reuters Monkeypox Emergency Could Last Months, According To Experts

Via Benzinga

New GSK Q2 Highlights: Shingles Vaccine Back In Demand, Antibiotics Recover, Forecast Boost ↗

July 27, 2022

Via Benzinga

Codexis Shares Slide On CEO Transition ↗

July 18, 2022

Via Benzinga

GSK Completes Spin Off Of Its Consumer Healthcare Business ↗

July 18, 2022

Via Benzinga

GSK Shares Encouraging Data From Chronic Hepatitis B Candidate ↗

June 27, 2022

Via Benzinga

7 Dividend Stocks to Buy on the Dip ↗

July 27, 2022

The stock market is volatile and bottoming, making it a good time to buy dividend stocks on the dip. Here are seven worth your consideration.

Via InvestorPlace

This Analyst Says GSK Spin-Off Haleon Offers "Best Of Both Consumer Worlds" ↗

July 22, 2022

Citi group has initiated coverage on GSK plc's (NYSE: GSK) consumer healthcare spin-off Haleon Plc (NYSE: HLN) with a Buy rating and a price target of 360p.

Via Benzinga

3 Biotech Stocks to Buy on the Dip ↗

July 21, 2022

Biotech stocks have rebounded lately and are poised to keep surging, so it's a good time to buy biotech stocks on the dip.

Via InvestorPlace

Benzinga Before The Bell: Musk's Twitter Lawsuit, Uber Penalized For Overcharging People With Disabilities, Johnson & Johnson Cuts Outlook And Other Top Financial Stories Tuesday, July 19 ↗

July 19, 2022

CNBC Amazon Courts More Trouble As Regulators Inspect Its Warehouses

Via Benzinga

Best Stocks For 2022 Recession ↗

June 18, 2022

Recession is in the air in 2022, and I have 3 stocks for recession-proofing your portfolio. Let's look at Walmart, Raytheon Tech, and GlaxoSmithKline.

Via Talk Markets

Post Mega London Stock Exchange Listing, GSK Spinoff Haleon's Plunge Brings Valuation Concerns To The Fore ↗

July 19, 2022

After GSK (NYSE: GSK) spun off its consumer health division Haleon Plc (LSE: HLN) into a separate entity, shares of the newly listed firm plunged during intraday trade, closing over 6.5% down at...

Via Benzinga

Air Pollution is a Global Heart and Lung Health Concern

July 18, 2022

Palm Beach, FL – July 18, 2022 – FinancialNewsMedia.com News Commentary – Particulate matter or particle pollution is a significant contributor to heart and lung disease. Individuals most affected by...

Via FinancialNewsMedia

Benzinga Before The Bell: Amazon Wages Price War On Tesco, Biden's Campaign Promise To Free Cannabis Prisoners, H&M Exits Russia And Other Top Financial Stories Monday, July 18 ↗

July 18, 2022

Reuters GSK Completes Spin-Off Of Its Consumer Healthcare Business

Via Benzinga

The Daily Biotech Pulse: Much Awaited FDA Nod For Novavax's COVID-19 Shot, DSMB Suggests ContraFect To Stop Antimicrobial-Resistant Infection Study, CytomX Restructures ↗

July 14, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Theravance Biopharma, Innoviva Gain On Selling TRELEGY ELLIPTA Royalty Interests ↗

July 13, 2022

Via Benzinga

Science Wednesday: Where To See Comet K2 As It Passes The Earth ↗

July 13, 2022

Five years ago, astronomers were electrified to confirm the discovery of Comet C/2017 K2, more commonly known as Comet K2. At the time, it was believed to be one of the largest comets zooming across...

Via Benzinga

The Daily Biotech Pulse: GSK To Supply 50M Flu Vaccine Doses To US, FDA Lifts Hold On Greenwich's Cancer Immunotherapy Trial, Connect Biopharma Sees CBP-201 Topline Data Sooner ↗

July 12, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

GSK prepares US for 2022-23 flu season with over 50 million influenza vaccine doses

July 11, 2022

From GSK plc

Via Business Wire

7 Retirement Stocks to Buy in July ↗

July 01, 2022

Planning for retirement can feel overwhelming in bear markets, but these seven retirement stocks can provide a boost to savings. Caterpillar (CAT): The

Via InvestorPlace

GSK Selects Target the Future Grant Recipient in Innovation Challenge Supporting Multiple Myeloma Community

June 29, 2022

From GSK plc

Via Business Wire

Ideaya Nominates Potential First-In-Class Pol Theta Helicase Inhibitor In Collaboration With GSK ↗

June 28, 2022

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

June 27, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies ↗

June 27, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

With Zero Revenue, Laekna Plays Chicken-And-Egg Game With Investors ↗

June 24, 2022

Key Takeaways: Laekna is seeking a Hong Kong IPO to raise funds to accelerate the commercialize two core products licensed from Novartis The company currently is not generating...

Via Benzinga

Finally An Omicron-Blocking Shot? Sanofi, GSK Say Yes ↗

June 24, 2022

The companies' shot was more than 93% effective in previously infected people.

Via Investor's Business Daily

Benzinga Before The Bell: Gun Safety Bill. Bill Gates's North Dakota Outrage, Sanofi-GSK's Covid-19 Vaccine's Omicron Efficacy And Other Top Financial Stories Friday, June 24 ↗

June 24, 2022

Reuters

Via Benzinga

Sanofi-GSK's Beta-Containing COVID-19 Vaccine Shows Efficacy Against Omicron ↗

June 24, 2022

Via Benzinga

This Pharmaceutical Company Is Moving Beyond CBD ↗

June 23, 2022

The applications for cannabidiol (CBD) and cannabinoid-based therapeutics are many. Many novel treatments have been, and are continuing to be, discovered using these compounds. The industry is huge...

Via Benzinga

< Previous 1 2

...

28 29 30 31 32 33 34 35 36

...

45 46 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

More ways to get to us

Facebook

Twitter

YouTube

ePaper Login
Subscribe
Subscription Services
Archive

About Us

The Lethbridge Herald
Other Publications
Food For Thought

Contact
Careers

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

Advertising
Terms and Conditions & Privacy Policy